Martin Doyle

Martin Doyle, our Head of Corporate Development and M&A at Esco, brings a wealth of experience to his role. Driven by a genuine passion for life sciences, he began his journey as a molecular biologist, conducting R&D in a genomics firm after graduate studies. After earning an MBA, he joined the corporate development group of a leading life science instruments and reagents provider, playing key roles in licensing, technology scouting, strategy, M&A, and integrating acquired companies.

As Head of Corporate Development and M&A, Martin oversees Esco’s growth and strategic evolution by identifying and executing initiatives to enhance our market position. His remit includes licensing agreements, technology scouting, M&A activities, and ensuring alignment with Esco’s business objectives. He also leads the seamless integration of acquisitions, fostering a cohesive, forward-thinking culture.

Martin’s leadership is defined by strategic innovation, measured decision-making, and leveraging Esco’s strengths in a dynamic industry. Facing rapid advances in genomics and proteomics, he champions continuous innovation and creativity. In a landscape dominated by larger suppliers, Martin advocates for Esco’s competitive edges—faster delivery, inventive products, and superior customer service.

His tenure at Esco is marked by significant contributions, especially in introducing fresh perspectives and best practices. By driving changes in product management, development, and organizational structure, he’s steering Esco toward its 3.0 transformation goals.